Centrum Homeopatiisp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-06-21
Share capital
50,000.00 PLN
Registered address
Miła 33, 01-050 Warszawa, Poland

Financials

Revenue history (in k)

Financial insight

  • The statement flags a going concern risk.

Filing timeliness

1 of 6 financial statements was filed late (for 2022, 4 days late), 1 not filed.

  • 202508/07/2026
  • 202411/04/2025
  • 202311/06/2024
  • 202219/07/2023
  • 2021not filed
  • 202012/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 57%
Division · Retail trade3,952 / 9,929
Top 40%
City · Warszawa12,105 / 57,023
Top 21%
Voivodeship · Mazowieckie17,084 / 77,210
Top 22%
Country · Poland67,053 / 298,279
Top 22%

Results vs industry

Revenue
This companyUSD 1.73mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -46.15kMedianUSD 20.70kAverageUSD 86.94k
Operating costs
This companyUSD 1.75mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 478.81kMedianUSD 543.65kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Centrum Homeopatii has been an NFZ healthcare provider since 2023. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmaciesmazowieckie1USD 0.00

Authorized Representatives

Małgorzata Marta Pociejage 53 – Członek

Manner of representation

Member of the management board independently

Ownership

OwnerSharesShare valueStake
999$13,492.7199.9%
Others
1$13.510.1%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1997-04-09.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $61,325.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
MagmaxS.A.
Novopharm - Millersp. j.
Farmiasp. z o.o. + limited partnership
Farmia Partnersp. j.
Pharma Nordsp. z o.o.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Macromedicasp. z o.o.
Inovpolsp. z o.o.
Nukloversp. z o.o.

Change history

DateEvent
2006-09-21Share capital increase
2001-06-21Entered in the register

FAQ

Last updated: 2026-10-27